Sepsis-Detecting
Point-of-Care Microfluidic Chip Developed
Sepsis is common and often deadly. Early detection of sepsis can be incredibly useful in preventing its full onset by allowing in-time administration of antibiotics.
A couple of biomarkers of oncoming sepsis is leukocyte count and neutrophil 64 (CD64), a neutrophil surface antigen. Researchers at the University of Illi**is have **w reported in journal
Nature Communications about a new
Point-of-Care Microfluidic biochip that only requires 10â??خ¼l of whole bloodآ*to count leukocytes and determine the concentration of CD64. They confirmed their readings against a traditional flow cytometer onآ*overnight hospital patients and those coming through an emergency room, showing a close correlation between the counts.
The device does **t require any preparation, and so can be used by just about anyone able to prick a finger, like diabetics do, to get a drop of blood. If made cheap e**ugh it may be used to regularly assess patients inside intensive care units and monitor the body’s immune response following administration of *****.
Study in
Nature Communications:
A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification…
Via:
University of Illi**is…
